The dramatic therapeutic effects of AGGF1 on mice with CAD and MI may be related to the beneficial effects of AGGF1-activated autophagy not only in ECs, but also in cardiomyocytes and other cells. The gene discussed is AGGF1; the disease is myocardial infarction.